ArticleJournal of medical cases2026

Cyclophosphamide for the Treatment of Refractory Immune Effector Cell-Associated Neurotoxicity Syndrome Following CD19-Targeted CAR T-Cell Therapy.

Austin Frisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.